Abstract
BackgroundDespite the remarkable efficacy achieved by CAR-T therapy in hematologic malignancies, application in solid tumors has been challenging. We previously developed human CAR-M and demonstrated that adoptive transfer of CAR-M...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have